D-0258-2026 Class II Ongoing
FDA drug recall D-0258-2026 was initiated by Advanced Pharmaceutical Technology, Inc. on Oct 3, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets. The recall status is ongoing. Affected quantity: 22,843 pellets.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 21, 2026
- Initiation Date
- Oct 3, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 22,843 pellets
Product description
TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01
Reason for recall
Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
Distribution pattern
GA, NY, TX, Puerto Rico, United Kingdom, Malta, Greece
Code information
Lot #: P-22-3, Exp 06-2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0258-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026